Renata PLC has shipped its first batch of 250 mg Terbinafine tablets, valued at £1,50,000, to the UK market. The tablets were manufactured in Rajendrapur, Gazipur, and the facility is approved by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). The company announced this via a disclosure on the Dhaka Stock Exchange (DSE) website. Terbinafine, marketed as Terbimax in Bangladesh, treats onychomycosis of the toenail or fingernail. Renata entered the UK market in 2018 through its subsidiary and currently commercializes several products with five distribution partners. Renata manufactures, markets, and distributes medicines, nutritional products, vaccines, and veterinary medications.
BIZDATAINSIGHTS
Bizdata Insights is a Market Insights, Data Intelligence and Business Advisory Platform
Our Solutions
Menu
Newsletter
Sign up for our newsletter now by entering your e-mail address and never miss out on the latest news and updates from our team!